Treatment history and association between allergic rhinitis symptoms and quality of life.
Marlene M SpethLloyd P HoehleKatie M PhillipsDavid S CaradonnaStacey T GrayAhmad R SedaghatPublished in: Irish journal of medical science (2018)
In persistent AR despite consistent ICS use, nasal symptoms may be the dominant drivers of AR-associated decreased general health-related QOL in contrast to persistent AR on no medication, when extranasal symptoms of AR are most significant. Longitudinal study is needed to investigate whether these results are predictive of responsiveness to ICS.